Ovarian Cancer Trial, Not Yet Recruiting (NCT06925126)

Ovarian Cancer Trial, Not Yet Recruiting NCT06925126 Sponsor: Fudan University Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06925126 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a woman aged 18 or older
You have been diagnosed with ovarian cancer (a specific type called epithelial ovarian cancer, confirmed by lab testing) at any stage, and have received no more than 2 previous rounds of treatment (not counting maintenance therapy)
Your cancer came back more than 6 months after your last platinum-based chemotherapy, and it responded well to that chemotherapy (meaning it shrank or disappeared)
Your returned cancer has been confirmed on a scan or imaging test
You are generally well enough to carry out basic daily activities (your doctor can assess this using a standard health scale)
You are expected to live for at least 6 more months
You are willing and able to give written consent to take part

Who may not be able to join:

Your ovarian cancer is not the epithelial type
You have had another type of cancer in the past 5 years (except for certain fully removed skin cancers — confirm with trial site)
You are currently pregnant, breastfeeding, or planning to become pregnant during the study
You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-21-64175590-81000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06925126

Sponsor: Fudan University

Phase: Not Applicable

Status: Not Yet Recruiting

Condition: Ovarian Cancer

Trial contact: 86-21-64175590-81000

More information: https://clinicaltrials.gov/study/NCT06925126

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a woman aged 18 or older
You have been diagnosed with ovarian cancer (a specific type called epithelial ovarian cancer, confirmed by lab testing) at any stage, and have received no more than 2 previous rounds of treatment (not counting maintenance therapy)
Your cancer came back more than 6 months after your last platinum-based chemotherapy, and it responded well to that chemotherapy (meaning it shrank or disappeared)
Your returned cancer has been confirmed on a scan or imaging test
You are generally well enough to carry out basic daily activities (your doctor can assess this using a standard health scale)
You are expected to live for at least 6 more months
You are willing and able to give written consent to take part

Who may not be able to join:

Your ovarian cancer is not the epithelial type
You have had another type of cancer in the past 5 years (except for certain fully removed skin cancers — confirm with trial site)
You are currently pregnant, breastfeeding, or planning to become pregnant during the study
You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Not Applicable

Sponsor

Fudan University

Registry

ClinicalTrials.gov

Start date

1 June 2025

Est. completion

1 June 2027

Primary endpoints

Recurrence-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov